Form 4 for MASS 908 Devices Inc.
Accepted 2021-08-30 00:00:00 ET · period of report 2021-08-27 · accession 0001562180-21-005631 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-08-30 | 2021-08-27 | MASS | Basarsky Trent A. | VP, Corp. Development | S - Sale+OE | $34.96 | -2,003 | 35.0K | -5% | -$70.0K |
| DM | 2021-08-30 | 2021-08-27 | MASS | Basarsky Trent A. | VP, Corp. Development | M - OptEx | $1.75 | +2,003 | 35.7K | +6% | +$3,505 |
| DM | 2021-08-30 | 2021-08-27 | MASS | Basarsky Trent A. | VP, Corp. Development | M - OptEx | $0.00 | -2,003 | 85.8K | -2% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-08-27 | S | D | 2,003 | $34.96 | 35,000 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.90 to $35.18, inclusive. The reporting person undertakes to provide to 908 Devices Inc., any security holder of 908 Devices Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. |
| 2 | Common | Common Stock | 2021-08-27 | M | A | 139 | $1.75 | 37,003 | D | — | — | |
| 3 | Common | Common Stock | 2021-08-27 | M | A | 1,136 | $1.75 | 36,864 | D | — | — | |
| 4 | Common | Common Stock | 2021-08-27 | M | A | 728 | $1.75 | 35,728 | D | — | — | |
| 5 | Derivative | Stock Option (Right to Buy) | 2021-08-27 | M | D | 1,136 | $0.00 | 84,643 | D | $1.75 · — to 2027-04-26 | 85,779 Common Stock | (F3) Twenty-five percent of the shares underlying the option became vested and exercisable on January 8, 2018 and the remaining 75% of the shares underlying the option become vested and exercisable in substantially equal monthly installments over the 36 months following January 8, 2018, subject to the reporting person's continued service through the applicable vesting date. |
| 6 | Derivative | Stock Option (Right to Buy) | 2021-08-27 | M | D | 139 | $0.00 | 84,504 | D | $1.75 · — to 2027-04-26 | 84,643 Common Stock | (F3) Twenty-five percent of the shares underlying the option became vested and exercisable on January 8, 2018 and the remaining 75% of the shares underlying the option become vested and exercisable in substantially equal monthly installments over the 36 months following January 8, 2018, subject to the reporting person's continued service through the applicable vesting date. |
| 7 | Derivative | Stock Option (Right to Buy) | 2021-08-27 | M | D | 728 | $0.00 | 85,779 | D | $1.75 · — to 2027-04-26 | 86,507 Common Stock | (F3) Twenty-five percent of the shares underlying the option became vested and exercisable on January 8, 2018 and the remaining 75% of the shares underlying the option become vested and exercisable in substantially equal monthly installments over the 36 months following January 8, 2018, subject to the reporting person's continued service through the applicable vesting date. |